Results 251 to 260 of about 10,004,929 (375)

Surgical Oncology Focusing on Minimally Invasive Surgery, More Randomized Clinical Trials

, 2001
Laura Newman
openalex   +1 more source

Book Review: Brain Cancer. American Cancer Society Atlas of Clinical Oncology [PDF]

, 2002
Frank D. Vrionis
openalex   +1 more source

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Journal of Oncology Practice, 2018
J. Brahmer, C. Lacchetti, John A Thompson   +2 more
semanticscholar   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Competing risks data in clinical oncology. [PDF]

Front Oncol
Kim HT.
europepmc   +1 more source

Distress Management Clinical Practice Guidelines in Oncology [PDF]

, 2003

openalex   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update. [PDF]

Cancer Commun (Lond)
Wang F, Chen G, Zhang Z, Yuan Y, Wang Y, Gao YH, Sheng W, Wang Z, Li X, Yuan X, Cai S, Ren L, Liu Y, Xu J, Zhang Y, Liang H, Wang X, Zhou A, Ying J, Li G, Cai M, Ji G, Li T, Wang J, Hu H, Nan K, Wang L, Zhang S, Li J, Xu RH.   +29 more
europepmc   +1 more source

Where Now with Training in Clinical Oncology?

, 2001
Christopher M. Nutting, Susan Short
openalex   +1 more source

Clinical research in pancreatic cancer: The Radiation Therapy Oncology Group trials [PDF]

, 2003
Christopher G. Willett, Howard Safran, Ross A. Abrams, William F. Regine, Tyvin A. Rich   +4 more
openalex   +1 more source